<\/p>\n
Adamax is a research peptide developed as a structural analogue of Semax, modified with an adamantane fragment (the same stabilizing motif used in P21). It is studied for endurance, recovery from physical exertion, and cognitive support \u2014 with research models reporting 2\u20133\u00d7 greater endurance effects than earlier Semax analogues. Sold as a research compound; not approved for human therapeutic use.<\/p>\n<\/div>\n
Adamax is an investigational peptide derived by modifying the Semax molecule with an adamantane fragment \u2014 the same hydrocarbon cage structure found in the nootropic candidate P21. That modification meaningfully alters two properties: membrane permeability and resistance to proteolytic breakdown. Both translate, in preclinical research, into longer duration of action and more consistent blood\u2013brain barrier penetration.<\/p>\n
Scientific interest in Adamax centers on three parallel research threads: (1) endurance and recovery under sustained physical load, (2) brain-derived neurotrophic factor (BDNF) expression in the hippocampus, and (3) sensitivity of the TrkB receptor \u2014 a key signaling hub for neuronal plasticity, memory consolidation, and mood regulation. These are the same pathways targeted by many classical nootropics, but Adamax’s adamantane stabilization allows it to be dosed less frequently while maintaining plasma and CNS concentrations.<\/p>\n
Adamax shares Semax’s Pro-Gly-Pro backbone, a fragment derived from adrenocorticotropic hormone (ACTH) with no hormonal activity of its own. What it brings to the parent molecule is metabolic stability \u2014 where unmodified Semax is cleared quickly by peptidases, Adamax resists enzymatic degradation and produces a more sustained downstream signal.<\/p>\n
Three mechanisms have been described in research publications:<\/p>\n
Research reports suggest the adamantane modification produces endurance effects roughly two to three times stronger than the parent Semax molecule when dosed on an equivalent molar basis. For a detailed treatment of the Semax lineage and the broader nootropic-peptide family, see our Semax peptide guide<\/a>.<\/p>\n Adamax is supplied lyophilized (freeze-dried). Laboratories typically reconstitute it with bacteriostatic water before use \u2014 our BAC Water product<\/a> is formulated for this purpose, and the BAC Water reconstitutiegids<\/a> walks through the standard protocol.<\/p>\n Dosing in published research protocols varies by endpoint. For endurance and physical-recovery studies, intranasal administration of 200\u2013400 \u00b5g once or twice daily is common. For cognitive endpoints, higher single doses up to 600 \u00b5g have been used. These figures reflect laboratory research conditions and are not prescribing recommendations \u2014 Adamax is not approved for therapeutic use in any jurisdiction.<\/p>\n Cycle length in research settings typically ranges from 10 to 21 days, followed by a washout period at least equal in length. Extended continuous exposure has not been adequately characterized.<\/p>\n As a modified Pro-Gly-Pro heptapeptide with no receptor binding outside the BDNF\/TrkB axis and mild HPA modulation, Adamax has a research-phase safety signal similar to Semax: generally well tolerated in short-term use, with occasional reports of headache, mild insomnia if dosed late, and transient nasal irritation with intranasal administration.<\/p>\n The longer half-life conferred by the adamantane modification is a double-edged sword \u2014 it improves dosing convenience but also means adverse effects, if they occur, persist longer. Research personnel should start at the low end of the dose range and avoid late-day administration.<\/p>\n Contraindications in research protocols: pregnancy, lactation, active psychiatric medication, and any acute neurological condition under investigation. Because long-term human safety data is absent, Adamax is explicitly restricted to laboratory research and is not sold for therapeutic self-administration.<\/p>\n Adamax sits in the cognitive-enhancement branch of the peptide research landscape. Related research compounds frequently investigated alongside it include:<\/p>\n \ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\nReconstitution, Storage & Handling<\/h2>\n
\n
Research Dosing Protocols<\/h2>\n
Veiligheidsprofiel<\/h2>\n
Adamax in the Peptide Cluster<\/h2>\n
\n
Why order Adamax from MedsBase<\/h3>\n
\n